Cybin (OTCMKTS:CLXPF) Shares Down 5.7% - What's Next?

Key Points

• Cybin Inc. (OTCMKTS:CLXPF) shares declined by 5.7% during mid-day trading, falling from a previous close of $7.60 to a last traded price of $7.17.
• The company's trading volume was down 15% from its average, with 471,407 shares changing hands compared to the typical 551,962.
• Cybin specializes in developing psychedelic therapeutics for psychiatric and neurological conditions, operating through two segments: Serenity Life and Natures Journey.

Cybin Inc. (OTCMKTS:CLXPF - ) traded down 5.7% during mid-day trading on Friday . The company traded as low as $7.04 and last traded at $7.17. 471,407 shares traded hands during trading, a decline of 15% from the average session volume of 551,962 shares. The stock had previously closed at $7.60.

Cybin Stock Down 5.7%

The stock has a fifty day moving average of $7.88 and a 200-day moving average of $7.68. The stock has a market cap of $1.07 billion and a PE ratio of -29.88.

Cybin Company Profile

Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.